Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Bleeding After Robot-assisted Radical Prostatectomy: a Respective Study

NCT06299046 · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Updated 8 March 2024

What is being tested
robot-assisted radical prostatectomy
For
Prostate Cancer; Bleeding; Prostate Adenocarcinoma
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 194 people. The full rules are on the registry page.
Where
Italy
When
Starts or started 1 Dec 2022, ends 1 Jan 2023. Registered 7 March 2024.
Results
None posted yet.

In the researchers' words

Nowadays robot-assisted radical prostatectomy (RARP) has become the standard surgical treatment for localised prostate cancer. The robotic approach has been proven superior to open retropubic prostatectomy (ORP) in terms of surgical-related morbidity: RARP has in fact been associated with significantly lower estimated blood loos (EBL), lower transfusion rate, less length of stay, shorter catheterization time, lower risk of Clavien-Dindo grade II and III complications, lower risk of vesicourethral anastomotic stricture and less post-operative pain. The optimal anatomical visualisation and the extraordinary maneuverability, along with the tamponade effect of the pneumoperitoneum, are surely to be deemed responsible of this statistically significant differences. However, to this day no study has ever investigated the prognostic significance of haematological parameters in terms of predicting perioperative bleeding risk in patients undergoing RARP. Therefore, the investigators conducted a retrospective non-interventional cohort study to gather evidence concerning the impact of anemia and thrombocytopenia on bleeding risk following this surgical procedure. Furthermore, the investigators evaluated associations between demographical, pathological and surgical factors and hemorrhagic complications. The investigators retrospectively evaluated all the patients that underwent…
ClinicalTrials.gov, NCT06299046

Sites

  • IRCCS Fondazione Ca' Granda Ospedale Maggiore PoliclinicoMilan, Italy